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Background
It is now well-known that a critical part of normal heal-
ing for cutaneous wounds is the formation of new blood
vessels. As implantation of autologous bone marrow
(BM)-derived Endothelial Progenitor Cells (EPC) into
ischemic limbs has become a promising treatment for
moderate to severe peripheral arterial occlusive disease
(PAD), we have begun a Phase II randomized trial in
Type 2 diabetes mellitus (T2DM). The goal of infusions
is to promote neoangiogenesis, thereby increasing circu-
lation, reducing symptoms, and facilitating wound heal-
ing. At first, we have studied EPC and gene expression
profile (GEP) of peripheral blood, hypothesizing that it
is possible to identify useful markers for the assessment
of the severity of endothelial dysfunction.
Methods and results
Using the high-performance flow cytometer FACSCanto,
we analysed peripheral blood samples from diabetic
patients and healthy donors. We found that T2DM
did not affect the number of early EPC, but greatly
decreased the number of highly differentiated EPCs. In
addition, T2DM increases the presence of both live and
dead circulating endothelial cells (CEC), together with
an increase in the number of activated CEC.
Relative quantification of 96 genes (TaqMan® Low Den-
sity Array) has been investigated. Notably, GEP in T2DM
was always different from that found in controls. In particu-
lar, patients showed abnormal expression of VEGFs, AFGs,
MMPs, TIMPs, CXCL12, HIF-1 alpha, IL-8 and AMPK.
Computational intelligence methods (NeuCom,
WWKNN and TWNFI) for discovering important infor-
mation from biological data were used for PAD risk
prediction.
Conclusions
Our results suggest that (i) the endothelial damage is
due more to an altered process of maturation/commit-
ment/homing of EPC than just to a simple decrease in
their production, ii) CEC could be useful markers for
the assessment of endothelial dysfunction severity, (iii)
GEP allows early identification of the patients, at risk
for PAD development, who might benefit of stem cell
therapy.
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